Chia–ming Chu

Chia–ming Chu's AcademicInfluence.com Rankings

Chia–ming Chu

Philosophy

#9270

World Rank

#12804

Historical Rank

Logic

#6254

World Rank

#7755

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Chia–ming Chu's Degrees

PhD Medical Sciences National Taiwan University
Doctorate Medicine National Taiwan University

Why Is Chia–ming Chu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Chia–ming Chu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Long‐term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B (2002) (689)
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study (1988) (638)
Hepatitis B virus infection (2009) (592)
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy (1999) (528)
Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection (1999) (458)
Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum (1985) (404)
Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. (1983) (350)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. (2002) (326)
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. (2007) (325)
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. (1986) (323)
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long‐term follow‐up (2007) (323)
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study (1991) (314)
Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. (1997) (306)
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. (2004) (286)
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. (2004) (236)
Clearance of the original hepatitis B virus YMDD‐motif mutants with emergence of distinct lamivudine‐resistant mutants during prolonged lamivudine therapy (2000) (227)
Determinants for sustained HBeAg response to lamivudine therapy (2003) (225)
Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. (1987) (202)
Hepatitis B virus-related cirrhosis: natural history and treatment. (2006) (202)
Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients (2013) (200)
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma (2000) (188)
Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. (2008) (170)
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. (2007) (170)
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. (2005) (170)
Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time (2009) (168)
Age‐specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B (2010) (162)
Hepatitis B surface antigen seroclearance during chronic HBV infection (2010) (161)
Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody‐positive patients (1987) (157)
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion (2007) (155)
Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. (1992) (150)
Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. (1994) (149)
Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis. (1985) (134)
Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. (1994) (122)
The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. (1994) (117)
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. (2008) (117)
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study (2007) (106)
Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus (2009) (100)
Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus (1999) (98)
Low-Level Viremia and Intracellular Expression of Hepatitis B Surface Antigen (HBsAg) in HBsAg Carriers with Concurrent Hepatitis C Virus Infection (1998) (96)
Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion (2002) (94)
Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. A clinicopathological study. (1985) (92)
T‐cell–mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection (1995) (92)
Determinants for hepatitis B e antigen clearance in chronic type B hepatitis. (2008) (89)
Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan (1998) (88)
Age‐specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (1984) (87)
Natural history of chronic hepatitis B virus infection: An immunopathological study (1997) (86)
Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? (2007) (83)
Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B. (1995) (82)
Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes. (1996) (80)
Prednisolone Priming Enhances Th1 Response and Efficacy of Subsequent Lamivudine Therapy in Patients With Chronic Hepatitis B (2000) (80)
Clinical and Virological Course of Chronic Hepatitis B Virus Infection With Hepatitis C and D Virus Markers (1998) (80)
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis (1987) (79)
Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers. (1993) (75)
White count, ph and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis (1985) (73)
Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma (2000) (71)
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. (1994) (71)
Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection. (2012) (67)
Spontaneous relapse of hepatitis in inactive HBsAg carriers (2007) (65)
The etiology of acute hepatitis superimposed upon previously unrecognized asymptomatic HBsAg carriers (1989) (64)
The role of laparoscopy in the evaluation of ascites of unknown origin. (1994) (62)
A Genome-Wide Association Study on Chronic HBV Infection and Its Clinical Progression in Male Han-Taiwanese (2014) (59)
Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination (1991) (55)
Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without (2012) (54)
Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection (1987) (54)
Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. (1997) (54)
The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflect the level of viral replication in chronic hepatitis B virus infection (1997) (54)
Sex Difference in Chronic Hepatitis B Virus Infection: An Appraisal Based on the Status of Hepatitis B e Antigen and Antibody (2007) (54)
HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis (1987) (51)
Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis (2008) (48)
Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. (1990) (48)
Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B. (1995) (47)
Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic (1996) (44)
Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study. (1996) (43)
Prevalence and prognostic significance of bacterascites in cirrhosis with ascites (1995) (43)
Comparison of long‐term effects of lymphoblastoid interferon alpha and recombinant interferon alpha‐2a therapy in patients with chronic hepatitis B (2004) (42)
Relative Roles of HBsAg Seroclearance and Mortality in the Decline of HBsAg Prevalence With Increasing Age (2010) (41)
Changes of serum HBV-DNA in relation to serum transaminase level during acute exacerbation in patients with chronic type B hepatitis. (2008) (40)
Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan (1984) (40)
Jaundice after open heart surgery: a prospective study. (1984) (39)
Cellular immune responses in patients with dual infection of hepatitis B and C viruses: Dominant role of hepatitis C virus (1995) (38)
Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion (2012) (36)
Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection (2012) (36)
Hepatitis C virus infection facilitates gallstone formation (2005) (36)
[Subacute hepatic failure]. (1984) (34)
Identification of a Hepatic Factor Capable of Supporting Hepatitis C Virus Replication in a Nonpermissive Cell Line (2001) (34)
Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection (1992) (34)
Etiology of sporadic acute viral hepatitis in Taiwan: The role of hepatitis C virus, hepatitis E virus and GB virus‐C/hepatitis G virus in an endemic area of hepatitis A and B (1999) (34)
Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. (1997) (34)
Immunohistological study of intrahepatic expression of hepatitis B core and E antigens in chronic type B hepatitis. (1992) (34)
G1 phase dependent nuclear localization of relaxed‐circular hepatitis B virus DNA and aphidicolin‐induced accumulation of covalently closed circular DNA (1998) (33)
Clinical outcomes after spontaneous and nucleos(t)ide analogue‐treated HBsAg seroclearance in chronic HBV infection (2016) (33)
HLA Class i antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis (1988) (33)
Chronic Lobular Hepatitis: A Clinicopathological and Prognostic Study (2007) (32)
Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis. (2008) (31)
Amino acid substitutions in codons 9–11 of hepatitis C virus core protein lead to the synthesis of a short core protein product (2000) (30)
Diagnostic laparoscopy in ascites of unknown origin: Chang Gung Memorial Hospital 20-year experience. (2008) (30)
Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV (2002) (30)
Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase. (2010) (30)
Coexpression of intercellular adhesion molecule-1 and class I major histocompatibility complex antigens on hepatocyte membrane in chronic viral hepatitis. (1993) (30)
Correlation of mutational analysis to clinical features in Taiwanese patients with Gilbert's syndrome (2001) (29)
Studies on the composition of the mononuclear cell infiltrates in liver from patients with chronic active delta hepatitis (1989) (29)
Increased Incidence of Fulminant Hepatic Failure in Previously Unrecognized HBsAg Carriers with Acute Hepatitis Independent of Etiology (2005) (29)
Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: Incidence and risk factors (1996) (27)
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells (2003) (27)
The etiology of acute viral hepatitis in an endemic area of hepatitis A and B. (1983) (27)
Emergence of an S gene mutant during thymosin alpha1 therapy in a patient with chronic hepatitis B. (1998) (24)
Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C. (1995) (24)
Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. (2002) (24)
Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers. (2012) (22)
Absence of precore stop mutant in chronic dual (B and C) and triple (B, C, and D) hepatitis virus infection. (1994) (22)
Original articleT-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection☆ (1995) (21)
The prevalence and prognostic significance of spontaneous bacterial peritonitis in severe acute hepatitis with ascites (1992) (21)
Simultaneous acute infections with hepatitis non-A, non-B, and B viruses (1982) (20)
A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients (1996) (19)
Comparative Studies on Expression of α-Smooth Muscle Actin in Hepatic Stellate Cells in Chronic Hepatitis B and C (2008) (19)
Polyadenylation of the mRNA of hepatitis delta virus is dependent on the structure of the nascent RNA and regulated by the small or large delta antigen. (1994) (19)
The role of delta superinfection in acute exacerbations of chronic type B hepatitis. (2008) (18)
Viral Superinfection in Previously Unrecognized Chronic Carriers of Hepatitis B Virus with Superimposed Acute Fulminant versus Nonfulminant Hepatitis (1999) (18)
Chronic hepatitis with nonspecific histological changes. Is it a distinct variant of chronic hepatitis? (2008) (17)
Quantitative assessment of hepatitis C virus RNA by polymerase chain reaction and a digoxigenin detection system: comparison with branched DNA assay. (1997) (17)
Epidemiological characteristics, risk factors, and clinical manifestations of acute non‐A–E hepatitis (2001) (17)
A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices. (1992) (16)
The Window Period Between Hepatitis B e Antigen and Antibody in Chronic Type B Hepatitis (1984) (16)
Studies of circulating immune complexes and lymphocyte subpopulations in childhood IgM mesangial nephropathy. (1986) (16)
Viral Load, Genotypes, and Mutants in Hepatitis B Virus-Related Hepatocellular Carcinoma: Special Emphasis on Patients with Early Hepatocellular Carcinoma (2011) (16)
Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment (1994) (14)
Hepatitis delta virus infection in Taiwan. (1987) (14)
Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection. (2008) (14)
Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma. (2000) (14)
Treatment of chronic type B hepatitis in Southeast Asia. (1988) (13)
Low‐level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus‐hepatitis C virus coinfection (2004) (13)
Acute hepatitis delta virus superinfection in patients with liver cirrhosis. (1990) (13)
[A clinical study on acute hepatitis A---with special reference to its occurrence in HBsAg carriers]. (1983) (12)
Acute delta superinfection in a previously unrecognised HBsAg carrier with transient loss of HBsAg simulating acute non-A, non-B hepatitis. (1988) (11)
Intrahepatic expression of HBcAg in chronic HBV hepatitis: Lessons from molecular biology (1990) (11)
Serum levels of interferon-α and-γ in acute and chronic hepatitis B virus infection (1995) (11)
Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers. (1986) (11)
Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C (1998) (11)
Peripheral T-cell subsets in chronic type B hepatitis: correlation with biochemical and histological activities and hepatitis B e antigen/antibody status. (1984) (10)
Distinct composition of viral quasispecies between ascites and serum samples from patients with late stage chronic hepatitis C. (1996) (10)
Intrahepatic expression of pre-S1 and pre-S2 antigens in chronic hepatitis B virus infection in relation to hepatitis B virus replication and hepatitis delta virus superinfection. (1992) (10)
Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. (1995) (10)
Characterization of nuclear localization of a hepatitis B virus precore protein derivative P22 (2005) (10)
Immunopathology on Hepatocyte Expression of HBV Surface, Core, and x Antigens in Chronic Hepatitis B: Clinical and Virological Correlation (2010) (9)
[Chronic hepatitis in Taiwan. II. A clinical and laboratory study (author's transl)]. (1981) (9)
Different implications of stigmata of recent hemorrhage in gastric and duodenal ulcers (1988) (9)
Replication of hepatitis B in HBsAg‐positive siblings (2002) (9)
Immune Tolerance Phase of Chronic Hepatitis B. (2017) (8)
Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen. (2002) (8)
Quantitative assessment of serum hepatitis B virus DNA: comparison between two different methods (1997) (8)
Diagnosis of acute type B hepatitis by a solid phase u-antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective study. (2008) (8)
Serum levels of soluble Tac peptide in acute and chronic hepatitis B virus infection. (1989) (7)
HBsAg seroclearance in Asian patients: too high and too bad in Hong Kong. (2009) (7)
Prognosis of immune-tolerant phase chronic hepatitis B (2017) (7)
[Histocompatibility profile of hepatoma in Taiwan]. (1982) (7)
Intrahepatic expression of hepatitis B core and surface antigens in chronic hepatitis delta-virus infection. (1992) (7)
Why most patients with hepatitis delta virus infection are seronegative for hepatitis B e antigen. A prospective controlled study. (1991) (7)
Original articleCellular immune responses in patients with dual infection of hepatitis B and C viruses: Dominant role of hepatitis C virus☆ (1995) (7)
Intrahepatic expression of HBcAg and delta antigen in anti‐HBe positive HBsAg carriers with acute exacerbation or chronic active liver disease (1990) (6)
[Hematological abnormalities in acute viral hepatitis and acute hepatitis in HBsAg carrier]. (1991) (6)
Immunoglobulin class M anti‐hepatitis B core antigen for serodiagnosis of acute hepatitis: Pitfalls and recommendations (2006) (6)
Alteration of the subcellular localization of hepatitis B virus core protein by large but not small surface proteins. (1994) (6)
Natural History of Hepatitis B Virus Infection (2016) (6)
Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection (1991) (6)
[Studies on chronic hepatitis in Taiwan. I. Types and etiology]. (1981) (5)
In vitro effect of a bovine thymic extract (thymostimulin) on T-cell differentiation in cord blood lymphocytes. (1985) (5)
Identification of a novel pre‐S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen (2003) (5)
Spontaneous bacterial peritonitis and bacteremia in fulminant hepatic failure. (2000) (5)
Percutaneous tumor ablation or surgical resection for small hepatocellular carcinoma? (2007) (5)
Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases (2005) (5)
Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. (1993) (5)
Hepatocyte expression of HBcAg and serum HBeAg in hepatitis B: comparison of polyclonal and monoclonal antibodies during a trial of interferon. (1991) (4)
Gastric adenocarcinoma simulating benign gastric ulcer. (1992) (4)
A single serine mutation on the nuclear localization signal of hepatitis B virus core protein abolishes the inhibition of nuclear transport by surface proteins. (1995) (4)
[The etiology of adult acute viral hepatitis in Taiwan]. (1982) (4)
Indocyanine green clearance test in non-cirrhotic hepatitis patients: a comparison and analysis between conventional blood sampling method and Finger Piece Monitoring method. (1999) (4)
Secondary prevention of hepatitis C virus‐related hepatocellular carcinoma (2005) (3)
Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant. (2000) (3)
[A clinical and prognostic study of non-A, non-B hepatitis]. (1983) (2)
[Fulminating viral hepatitis--a clinical study]. (1986) (2)
Spontaneous bacterial peritonitis and bacteremia in fulminant hepatic failure (2000) (2)
Sequential Changes of Hepatitis C Virus Antibody Profiles during Treatment of Chronic Hepatitis C of Genotype 1b: Pretreatment Antibody Response to E2/NS1 Correlated Sustained Response (2004) (2)
Serodiagnosis of acute B hepatitis: comparison between a competitive binding radioimmunoassay and an enzyme linked immunosorbent assay for IgM antibody to hepatitis B core antigen. (1985) (2)
Prevalence and significance of intrahepatic hepatitis delta virus antigen expression in HBeAg-negative patients with chronic type-B hepatitis in Taiwan (1989) (2)
Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection (2002) (2)
A Prospective Study on the Prognostic Significance of Bridging Hepatic Necrosis in Acute Viral Hepatitis (1984) (2)
[Chronic hepatitis in Taiwan. III. Sex difference in chronic hepatitis]. (1982) (1)
Original contributionClinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers (1998) (1)
Pseudocyst formation after intertrochanteric fracture fixation: a case report. (2001) (1)
[A retrospective study on acute post-transfusion hepatitis (author's transl)]. (1980) (1)
[Nd-YAG laser endoscopy for the treatment of upper gastrointestinal bleeding]. (1983) (1)
Abnormal transcripts for caspase-activated DNase in human hepatoma cells (2002) (1)
Management of older patients with immunotolerant chronic hepatitis B infection. (2022) (1)
Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase” (2023) (1)
Purification and Characterization of a Naturally Processed Hepatitis B Virus Peptide Recognized by CD 8 1 Cytotoxic T Lymphocytes (2013) (1)
[Serum level of N-terminal peptide of procollagen type III in chronic liver disease]. (1987) (1)
[Small intestinal diseases complicated by malabsorption syndromes]. (1986) (1)
48 Interferon therapy reduces cirrhosis and hepatocellular carcinoma in HBeAg positive chronic hepatitis B (2006) (1)
Role of the ribozyme of hepatitis delta virus on the transcription after polyadenylation. (1994) (1)
Puriﬁcation and Characterization of a Naturally Processed Hepatitis B Virus Peptide Recognized by CD8 (cid:49) Cytotoxic T Lymphocytes (1996) (1)
Role of the Ribozyme of Hepatitis Δ Virus on the Transcription After Polyadenylation (1994) (1)
Natural Course of Chronic Hepatitis B Virus Infection (2012) (1)
Early Detection of Hepatacellular Carcinoma in Patients With Chronic Type B Hepatitis (1986) (1)
[The prognostic value of early endoscopy in peptic ulcers bleeding]. (1985) (1)
[A review of 1,000 percutaneous needle biopsies of the liver (author's transl)]. (1981) (0)
361 HBSAG LEVELS PREDICT HBSAG SEROCLEARANCE IN 3 YEARS: A MATCHED CASE CONTROL STUDY (2011) (0)
Reply: (2008) (0)
AUTHOR INDEX (2006) (0)
Organization of The Third International Symposium on Viral Hepatitis and Hepatocellular Carcinoma (1993) (0)
Medication-induced Esophageal Injury: Clinical Analysis of 28 Cases (1992) (0)
Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection. (2022) (0)
P669 A GENOME-WIDE ASSOCIATION STUDY ON PERSISTENT HBV INFECTION AND ITS CLINICAL SIGNIFICANCE IN MALE HAN-TAIWANESE (2014) (0)
[Studies of hepatitis markers in hemodialysis patients in Taiwan]. (1986) (0)
expression ofhepatitis B coreandE antigens in chronic typeBhepatitis (1992) (0)
The relative role of viral load and metabolic factors in the risk of cirrhosis in chronic hepatitis B (2010) (0)
Plenary sessions: oral presentations (2006) (0)
hepatitis B factors in the risk of cirrhosis in chronic The relative role of viral load and metabolic (2010) (0)
[Serum alkaline phosphatase in bacteremia (author's transl)]. (1982) (0)
[Histocompatibility profile of hepatitis in Taiwan (author's transl)]. (1982) (0)
High Prevalence of Hepatitis C Antibody in Patients with Tuberculosis Infection (2006) (0)
[Primary carcinoma of the gallbladder]. (1983) (0)
Chronic hepatitis after overt acute non-A, non-B post-transfusion hepatitis in Taiwan. (1982) (0)
Acutedelta superinfection inapreviously unrecognised HBsAgcarrier withtransient loss of HBsAgsimulating acute non-A, non-Bhepatitis (1988) (0)
Endosonographic Features of Metastatic Breast Cancer in the Esophagus: Report of a Case (2008) (0)
Natural history of chronic hepatitis B virus infection : An immunopathological study : Molecular biology, pathogenesis and clinics (1997) (0)
Reactivation of Hepatitis C Virus Superinfection in a Patient Seropositive for Hepatitis B e Antigen (2001) (0)
Preoperative Evaluation of Gastric Cancer by Laparoscopy: The Significance of Serosal Invasion (1990) (0)
Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: Lack of correlation with DNA polymerase response (1984) (0)
[The hepatic manifestation in bacteremia (author's transl)]. (1980) (0)
Polyadenylation ofthemRNAofhepatitis delta virus is dependent onthestructure ofthenascent RNAand regulated bythesmall orlarge delta antigen (1994) (0)
hepatocyte membrane in chronic viral hepatitis (0)
Letter to the Editor: Age at Hepatitis B e Antigen Seroconversion and Other Factors for Outcomes of Chronic Hepatitis B (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Chia–ming Chu?

Chia–ming Chu is affiliated with the following schools:

Chang Gung University